Mirodenafil

Phase II Trials

Also known as: SK3530, Mvix

Prescription Only — FDA Approved Medication

Educational Content Only

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. The FDA has not evaluated many of the peptides discussed here. Always consult a licensed healthcare provider before making any health decisions.

Overview

Mirodenafil is a PDE5 inhibitor developed in South Korea and approved there for the management of erectile dysfunction. Research has examined its pharmacological profile relative to other PDE5 inhibitors, with studies suggesting a rapid onset of action. It is not approved by the FDA.

Possible Uses

The following areas have been examined in research contexts. This does not constitute medical advice or imply proven efficacy in humans.

Sexual Function

Mechanism of Action

Inhibits phosphodiesterase type 5 (PDE5), preventing degradation of cyclic GMP in corpus cavernosum smooth muscle. Elevated cGMP promotes smooth muscle relaxation and penile vasodilation in response to sexual stimulation.

Safety Notes

Approved in South Korea. Safety profile similar to other PDE5 inhibitors (headache, flushing, dyspepsia). Contraindicated with nitrates. Not FDA-approved.

Want to learn more?

Ask Research Chat about Mirodenafil

Research Profile

Half-Life

~2.5 hours

Administration

oral tablet

Legal Status (US)

Approved in South Korea. Not FDA-approved in the United States.

229 indexed research passages

Related Peptides

Oxytocin

Oxytocin is a nine-amino acid neuropeptide hormone produced in the hypothalamus and released by the posterior pituitary, studied extensively for its roles in social bonding, trust, maternal behavior, uterine contraction, and lactation. It is FDA-approved for obstetric indications and has been extensively studied in clinical contexts including autism spectrum disorder and social anxiety.

PT-141

PT-141 (bremelanotide) is an FDA-approved melanocortin receptor agonist studied for its role in sexual arousal pathways. It is the first peptide approved specifically for hypoactive sexual desire disorder (HSDD) in premenopausal women.

Androstadienone

Androstadienone is an endogenous androgen derivative found in male sweat and axillary secretions, studied as a potential human chemosignal with effects on mood, social cognition, and neuroendocrine responses in females. Research has examined its ability to influence cortisol levels, attention to emotional stimuli, and social evaluation processes.

Tadalafil

Tadalafil is an FDA-approved phosphodiesterase type 5 (PDE5) inhibitor used clinically for erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. It is distinguished among PDE5 inhibitors by its long duration of action, with effects studied for up to 36 hours.